Sanket Koul

Novo Nordisk's Wegovy gets CDSCO nod for fatty liver disease indication

The approval makes Wegovy the first GLP-1 therapy cleared in India for treating adults with non-cirrhotic MASH and moderate-to-advanced liver fibrosis

India's pharma exports to UK may reach nearly $1 billion in FY27

Improved market access and zero tariffs under the India-UK trade agreement are expected to lift Indian pharmaceutical exports to over $980 million in FY27

Lenskart leases 88K sq ft office at Bharti Realty's Worldmark for ₹232 cr

The eyewear retailer has signed a nine-year lease for office space at Worldmark 6 in Delhi's Aerocity, with monthly rentals of Rs 1.86 crore and a 15 per cent escalation every three years

Aurum Proptech acquires Housing.com for ₹458 cr, eyes AI integration

Firm aiming to build India's first AI Native Realty Operating System

Medtech firms seek curbs on third-country rerouting under India-UK CETA

Domestic medical device makers have sought stricter Rules of Origin and customs safeguards under the India-UK CETA to prevent third-country rerouting of imports into India

Andhra Covid deaths put states on alert; experts say no need for panic

After two Covid-19 deaths in Andhra Pradesh, neighbouring states have stepped up surveillance and testing, while health experts say current variants are mild and there is no need to panic

India office leasing falls 3.9% in H1 despite record net absorption: JLL

Office leasing fell 3.9 per cent in H1 2026 amid geopolitical uncertainty and AI-led business changes, while net absorption reached a record high, according to JLL

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Drug pricing authority allows five-year price cap exemption to Biological E's pneumococcal vaccine

Executive Centre India leases 114,950 sq ft at Worldmark for ₹309 cr

The flex workspace operator will pay rent for a chargeable area of 114,950 sq ft at Worldmark 6 in Delhi's Aerocity, with a 15 per cent escalation every three years

Prescription, licence must to sell drugs with high-alcohol content

Oral drug formulations containing over 12 per cent ethyl alcohol will require prescriptions and licensed retail sale under new rules aimed at curbing misuse and hoarding

India's declining fertility rates: Bihar, Meghalaya remain at the top

Almost every state and union territory shows a net decline in TFR over the last decade

Dr Reddy's to miss annual semaglutide supply target over API quality issue

Drugmaker says it will supply 6-7 million pens in the last two quarters of FY27 and restart production by November after resolving the API-related quality issue

ExxonMobil's India GCC leases 235,300 sq ft space in Bengaluru for ₹70.3 cr

ExxonMobil Services and Technology has leased 235,300 sq ft of office space at Bengaluru's International Tech Park Bangalore, with a total rental outgo of Rs 70.3 crore

Centre's IVF supply curbs to tighten oversight, formalise fertility sector

Executives say move unlikely to affect prices of IVF procedures

Nuvama, C&W JV fund achieves final close of ₹4k cr, eyes office investments

Nuvama and Cushman & Wakefield's Prime Offices Fund has achieved a final close of Rs 4,000 crore after strong investor demand and has already committed about 45% of its capital

Tier-II cities become real estate developers' next address for growth

Residential developers are expanding into India's Tier-2 cities as infrastructure upgrades, affordability and rising housing demand create new growth opportunities

Will step up tech-led healthcare expansion via Fortis: IHH Healthcare

Malaysia's IHH Healthcare plans to expand technology investments in India through Fortis, focusing on AI, precision medicine, advanced oncology and healthtech startups

Fortis signs O&M agreement for 300-bed hospital, enters Odisha market

Hospital chain Fortis Healthcare has signed an O&M agreement with Dion Group to operate a 300-bed hospital in Cuttack, marking its entry into Odisha and expanding its eastern India presence

As India expands QR tracking, pharma industry looks to AI for quality

While expanded traceability aims to curb counterfeit medicines, industry says predictive manufacturing could help reduce NSQ drugs

DPCO gets regulatory booster shot as govt eases compliance burden

Industry says amendments reduce procedural burden while tightening documentation and record-keeping norms for drug manufacturers under the pricing order